Hemab Therapeutics
#Biotech
Overview
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
Contact Details
info@hemab.com
Copenhagen, Denmark
Founded
2019
Employees
20-30
Categories
Keywords
#Biotech
Companies teams usually look at after Hemab Therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.